pemafibrate
Kowa Pharmaceuticals
[]
new medicine reduces triglyceride by 25%, no change in cvd risk in people with type 2 diabetes #aha22 
HeartNews delivers the latest news, information and resources about heart disease and stroke from the American Heart Association/American Stroke Association.